A randomized, double-blind, placebo-controlled trial of coenzyme Q10 in Huntington disease.

Author
:
A McGarry
M McDermott
K Kieburtz
EA de Blieck
F Beal
K Marder
C Ross
I Shoulson
P Gilbert
WM Mallonee
M Guttman
J Wojcieszek
R Kumar
MS LeDoux
M Jenkins
HD Rosas
M Nance
K Biglan
P Como
RM Dubinsky
KM Shannon
P O'Suilleabhain
K Chou
F Walker
W Martin
VL Wheelock
E McCusker
J Jankovic
C Singer
J Sanchez-Ramos
B Scott
O Suchowersky
SA Factor
Higgins DS Jr
E Molho
F Revilla
JN Caviness
JH Friedman
JS Perlmutter
A Feigin
K Anderson
R Rodriguez
NR McFarland
RL Margolis
ES Farbman
LA Raymond
Suski V
S Kostyk
A Colcher
L Seeberger
E Epping
S Esmail
N Diaz
WL Fung
A Diamond
S Frank
P Hanna
N Hermanowicz
LS Dure
M Cudkowicz
Coordinators. and
Abstract
:

To test the hypothesis that chronic treatment of early-stage Huntington disease (HD) with high-dose coenzyme Q10 (CoQ) will slow the progressive functional decline of HD.
Year of Publication
:
2017
Journal
:
Neurology
Volume
:
88
Issue
:
2
Number of Pages
:
152-159
Date Published
:
2017
ISSN Number
:
0028-3878
URL
:
http://www.neurology.org/cgi/pmidlookup?view=long&pmid=27913695
DOI
:
10.1212/WNL.0000000000003478
Short Title
:
Neurology
Download citation